Feb 10, 2023, 09:51 by

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for pharmaceutical intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Feb 10, 2023, 01:00 by User Not Found

Clinical Research News | At this week’s Summit for Clinical Ops Executives, Genentech’s Virginia Nido delivered a call to action to her industry peers, asking them to learn the landscape of collaboratively developed clinical trials solutions and start using them.

Feb 9, 2023, 11:02 by

RTsafe has announced that Spain’s Fundación Instituto Valenciano de Oncología has conducted its first simulated therapy for brain metastases using RTsafe’s patient-specific quality assurance process, PseudoPatient.

Feb 9, 2023, 11:01 by

BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting and payments, announced their partnership today. Through the partnership, BSI Life Sciences’ Clinical Trial Management software BSI CTMS™ and Ledger Run’s unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

Feb 9, 2023, 11:01 by

Feb 9, 2023, 11:01 by

Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA), optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac disease-related studies.

Feb 9, 2023, 11:01 by

Dolomite Bio has re-branded with a new website, a new name, and a new focus.

Feb 9, 2023, 11:00 by

Company increases laboratory capacity to meet customer demand for fully integrated drug development capabilities

Feb 9, 2023, 09:13 by User Not Found

Clinical Research News | ORLANDO—Clinical Research News and ClinEco announced the 2023 SCOPE Best of Show awards yesterday at SCOPE. Products from Anju Software, EmVenio, Medidata, StudyKIK, and uMotif took top honors.

Feb 8, 2023, 09:54 by

NDA Group announces the appointment of Erik Bech-Jansen as the new Chief Financial Officer.

Feb 7, 2023, 10:40 by

Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.

Feb 7, 2023, 10:40 by

As the new year approaches, BOC Sciences' January promotion is bang on time, as usual, to thank all regular customers for the year-round support and to welcome new partners to join.

Feb 7, 2023, 10:39 by

While increased investment in pharmaceutical research and development is creating more opportunities for Contract Research Organizations (CROs), many are struggling to keep pace with competitive pressures, changing market requirements, and a lack of skilled talent.  To help CROs meet these challenges, Oracle introduced its CRO Growth Initiative in August 2022. The global program offers CROs no-obligation access to Oracle Clinical One, a leading eClinical platform, for non-production purposes. Through the program, CROs can evaluate, familiarize, train, and enable their users with the technology and demonstrate the power of Clinical One to potential sponsors. Already, hundreds of CRO professionals have taken advantage of the program’s accelerator that provides go-to-market benefits, technical enablers, and incentives all constructed to help them to get trials up and running faster.

Feb 7, 2023, 10:39 by

Thermo Fisher Scientific and Celltrio have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.

Feb 7, 2023, 09:52 by User Not Found

Clinical Research News | A winner has been chosen for the 7th Annual Participant Engagement Award and was announced after a live presentation and judging session at the Summit for Clinical Ops Executives, on February 6, 2023, in Orlando, Fla.

Feb 7, 2023, 09:07 by User Not Found

Clinical Research News | In the latest episode of the Scope of Things podcast, Graham Hatfull, professor of biological sciences at the University of Pittsburgh, speaks with host Deborah Borfitz about his team’s work to showcase bacteriophages as versatile therapeutic agents.

Feb 6, 2023, 09:57 by

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies Risk-Based Quality Management: 10 Years of enhancing Quality, Accuracy, and Integrity across all Clinical Trial Data

Feb 6, 2023, 09:57 by

Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.

Feb 6, 2023, 09:56 by

Feb 6, 2023, 09:56 by